Literature DB >> 15714542

Rapid assessment of beta-asarone content of Acorus calamus by micellar electrokinetic capillary chromatography.

Kim M Hanson1, Melissa Gayton-Ely, Lisa A Holland, Peter S Zehr, Björn C G Söderberg.   

Abstract

This report outlines a rapid, reproducible method for the determination of beta-asarone, a known carcinogen, using micellar electrokinetic capillary chromatography (MEKC)-UV-vis absorbance and a simple alcohol extraction. The MEKC method is based on a running buffer comprised of 100 mM sodium dodecyl sulfate (SDS), pH 10. The method is reproducible and provides baseline separation of alpha-asarone and beta-asarone. This protocol was used to determine the beta-asarone content of Acorus calamus rhizome of a diploid variety harvested from the wetlands of the United States and the triploid variety from India obtained commercially. The results indicate raw product that originated from India contained 4.4% w/w beta-asarone, while that from the United States contained 0.2% w/w beta-asarone. Neither sample contained detectable concentrations of alpha-asarone. This is the first report of the use of MEKC to determine asarone in a natural source.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15714542     DOI: 10.1002/elps.200410165

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  3 in total

Review 1.  Experimental evidence for use of Acorus calamus (asarone) for cancer chemoprevention.

Authors:  Bhrigu Kumar Das; Ahm Viswanatha Swamy; Basavaraj C Koti; Pramod C Gadad
Journal:  Heliyon       Date:  2019-05-08

2.  Identification of both GABAA receptors and voltage-activated Na(+) channels as molecular targets of anticonvulsant α-asarone.

Authors:  Ze-Jun Wang; Simon R Levinson; Liqin Sun; Thomas Heinbockel
Journal:  Front Pharmacol       Date:  2014-03-11       Impact factor: 5.810

3.  Hepatotoxic potential of asarones: in vitro evaluation of hepatotoxicity and quantitative determination in herbal products.

Authors:  Dhavalkumar N Patel; Han K Ho; Liesbet L Tan; Mui-Mui B Tan; Qian Zhang; Min-Yong Low; Cheng-Leng Chan; Hwee-Ling Koh
Journal:  Front Pharmacol       Date:  2015-02-20       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.